Financials in USD. Standardized financial statements.
A compact view of how Medivir AB (publ) turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.41M | $25.54M | $13.95M | $8.72M | $23.86M | $36.64M | $93.04M | $657.89M | $1.77B | $446.15M |
| Revenue Growth? | -82.7% | +83.1% | +59.9% | -63.4% | -34.9% | -60.6% | -85.9% | -62.8% | +296.1% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $15.95M | $109.28M | $174.02M | $71.77M |
| Gross Profit? | $4.41M | $25.54M | $13.95M | $8.72M | $23.86M | $36.64M | $77.09M | $548.61M | $1.59B | $374.38M |
| Gross Margin? | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +82.9% | +83.4% | +90.2% | +83.9% |
| Operating Expenses? | $93.02M | $89.94M | $69.63M | $134.70M | $374.89M | $399.47M | $389.47M | $433.84M | $404.24M | $349.21M |
| Operating Income? | -$87.35M | -$62.12M | -$42.90M | -$125.98M | -$351.03M | -$362.83M | -$312.38M | $114.77M | $1.19B | $25.16M |
| EBITDA? | -$85.27M | -$59.03M | -$37.64M | -$114.93M | -$324.10M | -$334.26M | -$272.30M | $141.46M | $1.22B | $63.24M |
| Income Before Tax | -$88.77M | -$62.58M | -$42.62M | -$123.33M | -$350.48M | -$359.73M | -$306.73M | $101.95M | $1.19B | $27.63M |
| Income Tax Expense | $0 | $546,000 | $0 | $106,000 | -$161,000 | $490,000 | -$11.87M | $26.86M | $59.97M | $11.62M |
| Net Income? | -$88.77M | -$63.13M | -$42.62M | -$123.44M | -$350.31M | -$360.22M | $282.85M | $75.09M | $1.13B | -$21.34M |
| EPS? | $-1.59 | $-1.20 | $-1.44 | $-4.17 | $-12.01 | $-13.47 | $8.62 | $2.13 | $29.76 | $-0.56 |
| Diluted EPS? | $-1.59 | $-1.20 | $-1.44 | $-4.17 | $-12.01 | $-13.43 | $8.60 | $2.10 | $29.48 | $-0.56 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality